Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Normanno N"'
Autor:
Clorinda Schettino, Lucia Musacchio, Michele Bartoletti, Paolo Chiodini, Laura Arenare, Gustavo Baldassarre, Daniela Califano, Ettore Capoluongo, Maria Paola Costi, Maurizio D'Incalci, Sergio Marchini, Delia Mezzanzanica, Nicola Normanno, Stefania Scala, Stefano Greggi, Francesco Perrone, Sandro Pignata
Publikováno v:
International Journal of Gynecologic Cancer. 32:799-803
BackgroundPoly (ADP-ribose) polymerase inhibitors have transformed the management landscape for patients with ovarian cancer, demonstrating remarkable improvements in progression-free survival and overall survival. Unfortunately, most relapses are du
Autor:
Caterina Ieranò, Dario Righelli, Crescenzo D'Alterio, Maria Napolitano, Luigi Portella, Giuseppina Rea, Federica Auletta, Sara Santagata, Anna Maria Trotta, Giuseppe Guardascione, Federica Liotti, Nella Prevete, Piera Maiolino, Antonio Luciano, Antonio Barbieri, Annabella Di Mauro, Cristin Roma, Riziero Esposito Abate, Fabiana Tatangelo, Roberto Pacelli, Nicola Normanno, Rosa Marina Melillo, Stefania Scala
Publikováno v:
Journal for ImmunoTherapy of Cancer. 10:e004032
BackgroundColorectal cancer (CRC) is one of the most prevalent and deadly tumors worldwide. The majority of CRC is resistant to anti-programmed cell death-1 (PD-1)-based cancer immunotherapy, with approximately 15% with high-microsatellite instabilit
Autor:
De Bonis M; Departmental Unit of Molecular and Genomic Diagnostics, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy.; Genomics Research Core Facility, Gemelli Science and Technology Park (GSTeP), Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy., Nero C; Department of Woman, Child, and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy., Scambia G; Dipartimento Scienze della Salute della Donna e del Bambino, Fondazione Policlinico Universitario A Gemelli IRCCS, Roma, Italy., Normanno N; Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori, National Cancer Institute IRCCS Pascale Foundation, Napoli, Italy., Minucci A; Departmental Unit of Molecular and Genomic Diagnostics, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy angelo.minucci@policlinicogemelli.it.; Genomics Research Core Facility, Gemelli Science and Technology Park (GSTeP), Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy.
Publikováno v:
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2024 May 06; Vol. 34 (5), pp. 794-795. Date of Electronic Publication: 2024 May 06.
Autor:
Schettino C; Clinical Trial Unit, Istituto Nazionale Tumori, IRCCS, 'Fondazione Giovanni Pascale', Naples, Italy., Musacchio L; Department of Women and Child Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy, Rome, Italy., Bartoletti M; Unit of Medical Oncology and Cancer Prevention, Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy., Chiodini P; Department of Mental Health and Public Medicine, Section of Statistics, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy., Arenare L; Clinical Trial Unit, Istituto Nazionale Tumori, IRCCS, 'Fondazione Giovanni Pascale', Naples, Italy., Baldassarre G; Division of Molecular Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy., Califano D; Microenvironment Molecular Targets Unit, Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale, Naples, Italy., Capoluongo E; Department of Molecular Medicine and Medical Biotechnology, Università degli Studi di Napoli Federico II, Naples, Italy.; Azienda Ospedaliera per L'Emergenza, Cannizzaro, Catania, Italy., Costi MP; Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy., D'Incalci M; Laboratory of Molecular Pharmacology, Group of Cancer Pharmacology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy., Marchini S; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy., Mezzanzanica D; Molecular Therapies Unit, Department of Research, Istituto Nazionale dei Tumori IRCCS, Milan, Italy., Normanno N; Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori 'Fondazione Giovanni Pascale', Naples, Florida, USA., Scala S; Microenvironment Molecular Targets Unit, Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale, Naples, Italy., Greggi S; Gynecologic Oncology Surgery, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy., Perrone F; Clinical Trial Unit, Istituto Nazionale Tumori, IRCCS, 'Fondazione Giovanni Pascale', Naples, Italy., Pignata S; Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS 'Fondazione Giovanni Pascale', Naples, Italy, 80131 s.pignata@istitutotumori.na.it.
Publikováno v:
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2022 Jun 06; Vol. 32 (6), pp. 799-803. Date of Electronic Publication: 2022 Jun 06.